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Case Presentation
A 59 year-old female presented with visual problems in 2006, and was initially diagnosed with a pitu-
itary macroadenoma on MRI (Figure 1). Preoperatively, the pituitary lesion decreased in size after 
the patient was started on steroids, raising the possibility of lymphoma and inflammatory conditions. 
Ultimately, endoscopic trans-nasal biopsy of the pituitary lesion revealed lymphocytic hypophysitis. 
She was treated with steroids for two years and developed several side effects from chronic steroid 
use, including Cushingoid features, diabetes, cataracts, weight-gain and osteopenia. As a result, she 
was subsequently treated with methotrexate and gradual weaning of the steroids.
Tumor
Lymphocytic Hypophysitis
The latest MRI of the brain (Figure 2) revealed 
some thickening and enhancement within the 
sella and along the infundibulum. Overall the 
volume and degree of enhancement appeared 
unchanged compared to MRI’s over the past 
two years and seems to have reached a steady-
state on her current medication regimen. The 
patient is maintained on methotrexate 15 mg 
weekly and prednisone 5 mg daily for baseline 
hypocortisolemia. She states that she has been 
feeling well, has normalized vision, and reports 
an improvement in side-effects, including 
weight loss, less Cushingoid features, and 
better glycemic control.
We anticipate long-term management on the 
current regimen of methotrexate and predni-
sone as she has had several serial MRI scans 
and ophthalmology examinations that have 
remained stable.  Annual MRI scans will be 
obtained, and will be performed sooner if she 
develops symptoms of worsening disease or 
there is a change in the dose of methotrexate.
What is this disease?
Lymphocytic hypophysitis (LH) is an uncommon 
autoimmune disease in which the pituitary 
gland is infiltrated by lymphocytes, plasma cells 
and macrophages and its function is usually 
impaired.1 It was first described2 by Goudie 
and Pinkerton in 1962. Its annual incidence has 
been estimated at one case per 9 million and 
data from most series show that it is present 
in less than 1% of all surgical specimens.2 This 
may be an underestimate since the frequency of 
case reports has increased in recent years.  It has 
been most commonly described in post-partum 
women, but can occur outside this scenario. 
Some patients may also exhibit an autoimmune 
poly-endocrinopathy. 
Classification and Pathology
Anterior hypophysitis is the most common 
form, confined to the adenohypophysis. It causes 
adenohypophyseal destruction and hypopituita-
rism. Diabetes insipidus (DI) is uncommon.
Infundibular and posterior hypophysitis is 
much less common, causing diabetes insipidus 
and hyperprolactinemia from pituitary stalk 
dysfunction. This involves the neurohypophy-
sis and pituitary stalk. The anterior pituitary is 
usually preserved.
Lymphocytic infundibular panhypophysitis is 
a much rarer form with lymphocytic infiltra-
tion and destruction in both the anterior and 
the posterior parts of the pituitary gland. These 
Figure 2
Most recent coronal and sagittal T1 post-contrast MRI with patient on methotrexate treatment.
Figure 1
Pre-operative coronal and sagittal T1 post-contrast MRI. Note: suprasellar extension 
along infundibulum   
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patients develop pan-hypopituitarism and 
present with a combination of DI and anterior 
pituitary dysfunction. 
Pathogenesis
The disease is characterized by autoimmune 
pathogenesis with focal or diffuse inflamma-
tory infiltration (Figure 3) and varying degrees 
of pituitary gland destruction. It typically 
follows a course in which the pituitary gland 
initially increases in size simulating a mass, 
later followed by shrinkage due to fibrotic 
changes.4,5 Hypopituitarism with empty sella 
syndrome is a common final outcome when 
the inflammation resolves.
Clinical Findings
Symptoms include headaches, watery nasal 
drainage, facial pain, skin changes, dizziness, 
constipation, diarrhea, temperature intolerance, 
body hair loss, increased fatigue, seizures, 
weight gain or loss, sexual disorders and loss of 
libido, low blood pressure, visual disturbance 
and often bitemporal visual field loss secondary 
to chiasmal compression when there is an 
inflammatory mass effect. Other symptoms 
include anterior pituitary hypofunction (63%), 
diabetes insipidus (19%), hyperprolactinemia 
(38%), and autoimmune thyroditis (25%).6
Diagnosis and Investigations
A presumptive clinical diagnosis can be made 
if there is a history of gestational or postpartum 
hypopituitarism, a contrast-enhancing sellar 
mass with imaging features characteristic of 
lymphocytic hypophysitis, and a pattern of 
pituitary hormone deficiency with early loss of 
adrenocorticotrophic hormone (ACTH) and 
thyroid-stimulating hormone (TSH).  This is in 
contrast to the hormone loss pattern typically 
found with macroadenomas (i.e., sequential 
loss of growth hormone, luteinizing hormone/
follicle-stimulating hormone, and later ACTH, 
and TSH).
Biopsy is the only accurate means of diagno-
sis. Other investigations include MRI, clinical 
endocrinological assessment, CSF examination 
for lymphocytosis, elevated protein, and increased 
serum thyroglobulin antibody concentration. 
Biopsy is the only accurate means of diagnosis. 
Other investigations include MRI, clinical 
endocrinological assessment, CSF examination 
for lymphocytosis and elevated protein, and 
serum thyroglobulin antibody concentration. 
Imaging
Radiological findings include an enlarged pitu-
itary gland and suprasellar extension is common 
with possible involvement of the pituitary stalk. 
Radiographically, it can be differentiated from 
pituitary adenoma as shown in the table.7-10
Lymphocytic hypophysitis can be confused 
with macroadenoma as mentioned above, 
and also with gestational hypopituitarism, 
Figure 3. Lymphocytic Hypophysitis.  
The normal pituitary gland is replaced by a diffuse infiltrate of 
inflammatory cells and only few residual islands of residual glandular 
tissue 
3A) The normal pituitary gland is replaced by a diffuse infiltrate of 
inflammatory cells and only few residual islands of residual glandular 
tissue (Hematoxylin and Eosin stain) that can better appreciated by an 
immunohistochemical stain (brown) for chromogranin, a marker of 
neuroendocrine differentiation (3B). 
3C) An immunohistochemical stain (brown) for CD3, a lymphocyte 
marker, demonstrates the identity of the majority of the cells as 
T-lymphocytes.
Original magnification for all images – 200X.
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Tumor 
Sheehan syndrome, lymphoma, tuberculosis, 
sarcoidosis, or syphilis.11 There has been a case 
of suprasellar germinoma masquerading as 
lymphocytic hypophysitis12 and a case reported 
with lymphocytic hypophysitis and thyroiditis 
associated with aseptic meningitis where a viral 
illness was proposed to be the etiological cause.13
Management
Appropriate management remains controver-
sial due to limited clinical case studies owing to 
the rarity of this disease. 
Corticosteroid therapy has been advocated as a 
means of attenuating inflammation, but given 
the uncertainty of its efficacy and the known 
adverse effects, such therapy does not seem 
justified for most patients. Other immunosup-
pressants, such as methotrexate or cytoxan, 
offer the anti-inflammatory benefits of corti-
costeroids without the negative side-effects of 
long-term steroid use. 
The role of surgery is mainly for tissue diagnosis 
and is sometimes also indicated for decom-
pression of surrounding structures.7 Surgical 
decompression is indicated in the presence of 
symptomatic optic chiasm compression, in 
the face of ineffective steroid therapy, or the 
impossibility of establishing the diagnosis with 
sufficient certainty by less invasive means.11 
Gamma Knife surgery has been utilized14 for 
persistent refractory disease.
All patients with lymphocytic hypophysitis 
require close observation for pituitary hormonal 
hyposecretion and appropriate hormone 
replacement therapy. Long-term follow-up is 
mandatory to monitor for the development of 
other delayed hormonal deficits. Patients with 
a presumed diagnosis of lymphocytic hypoph-
ysitis should be observed closely and undergo 
serial visual field examinations, endocrine 
evaluation with blood work, and serial imaging 
studies until they are in remission. 
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Table
Lymphocytic Hypophysitis                       Pituitary Adenoma
Gland symmetrically enlarged Asymmetrically enlarged
Administration of gadolinium homogenously enhances the gland Often differential enhancement of the tumor and the pituitary gland
Hypointense on T1 and high signal on T2 weighted images Isointense on both T1 and T2 images
Unique contrast enhancement may involve adjacent dura mater and infundibulum Contrast enhancement, sellar and suprasellar, with expanded sella
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